Skip to main content
Open Access Publications from the University of California

Erythema annulare centrifugum-type eruption in a patient undergoing cancer vaccine immunotherapy

  • Author(s): Tadros, Joseph
  • Rahnama-Moghadam, Sahand
  • et al.
Creative Commons 'BY-NC-ND' version 4.0 license

Sipuleucel-T is a cellular immunotherapy approved for the treatment of metastatic castration-resistant prostate cancer. We report a patient developing an immune related adverse effect from sipuleucel-T drug-induced erythema annulare centrifugum-like eruption. A brief review of the mechanism and implications of this eruption are also included.

Main Content
Current View